Mumbai, August 08, 2015: Omkar Speciality Chemicals Ltd (OSCL), a leading company in the field of Speciality Chemicals and Active Pharmaceutical Ingredients (APIs), today declared its financial results for the first quarter ended June 30, 2015.
The company reported a healthy increase of 64.41% in its Net Profit to Rs. 8.17 crore for Q1FY16, as compared to Rs. 4.97 crore in the corresponding quarter of last fiscal.
Total Income for the quarter ended June 30, 2015 stood at Rs. 90.48 crore, as compared to Rs. 53.51 crore in the same period last year.
OSCL’s Earnings before Interest, Tax, Depreciation and Amortization (EBITDA) in Q1FY16 stood at Rs. 17.26 crore, up 98.02%. The company’s EBITDA margin improved from 16.29% in Q1FY15 to 19.08% in Q1FY16.
Commenting on the financial performance of the company Mr. Omkar Herlekar, the Whole Time Director, Omkar Speciality Chemicals Ltd, said, “It is great to start off this fiscal year with a robust increase in our top-line with the commencement of operations of the additional capacity at Chiplun. We believe traction in sales to continue over the coming quarters with a steady improvement in capacity utilization. The margins have increased because of higher composition of speciality chemicals and APIs in the total sales.”
Earnings per share (EPS) for the quarter ended Q1FY16 stood at Rs. 3.97, up 64.73% as compared with Rs. 2.41 for the quarter ended June 30, 2014.
CCI Newswire
